IP Library Patent Application 13958782
Patent Application
App. No. 13/958,782

METHODS OF IDENTIFYING AN ORGANISM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/958,782
Abstract

This disclosure features methods of identifying an organism. In certain embodiments, the invention provides methods of distinguishing virulent and non-virulent strains of Listeria monocytogenes.

Claims (13)

1 - 9 . (canceled)

10 . A method of distinguishing virulent and low- or non-virulent strains of Listeria monocytogenes, the method comprising:

obtaining a nucleic acid from L. monocytogenes;

preparing an optical map of one or more restriction digests of the obtained nucleic acid; and

detecting an insertion that is at least 1 kb in size in a clpP gene of a genome of L. monocytogenes, wherein the insertion results in inactivation of the clpP gene, which is indicative of a low- or non-virulent strain of L. monocytogenes.

11 . The method according to claim 10 , wherein the nucleic acid is obtained from at least one sample type selected from the group consisting of: a food sample, an environmental sample, and a human tissue or body fluid sample.

12 . The method according to claim 11 , wherein the environmental sample is selected from the group consisting of water, soil, sewage, and decaying vegetable matter.

13 . The method according to claim 11 , wherein the tissue or body fluid is from a human having a disease selected from the group consisting of meningitis, gastroenteritis, and septicemia.

14 . The method according to claim 10 , wherein the insertion is a 48.3 kb insertion.

15 . The method according to claim 10 , wherein the L. monocytogenes is classified as a serotype 4b strain.

16 . The method according to claim 10 , wherein the L. monocytogenes is classified as a serotype 1/2a strain.

17 . The method according to claim 10 , wherein the L. monocytogenes low- or non-virulent strain is selected from the group consisting of L. monocytogenes BO43 or L. monocytogenes 416.

18 . The method according to claim 10 , wherein the L. monocytogenes virulent strain is selected from the group consisting of L. monocytogenes strain 4b F2365, L. monocytogenes strain EGD-e, L. monocytogenes strain A23, L. monocytogenes Clip81459 ′4b CLIP80459′.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 3, 2021
From: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
To: OPGEN, INC.; ADVANDX, INC.
Reel/Frame 055209/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2016
From: ZENTZ, EMILY B.; DYKES, COLIN WILLIAM; BRISKA, ADAM MICHAEL
To: OPGEN, INC.
Reel/Frame 037643/0679 →
SECURITY INTEREST Recorded Aug 17, 2015
From: OPGEN, INC.; ADVANDX, INC.
To: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
Reel/Frame 036377/0129 →